| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 7 | +0.00% | +3.13% | -0.26% | +3.39% | +2.04% | — |
| 14d | 7 | +42.86% | -0.59% | +1.40% | -2.00% | -2.15% | — |
| 30d | 7 | +60.00% | -1.08% | +0.93% | +1.62% | +4.10% | — |
| 60d | 7 | +85.71% | -9.93% | +3.67% | -13.60% | -15.43% | — |
| 90d | 7(4 pending) | +100.00% | -9.92% | -0.13% | -9.80% | -9.52% | — |
| 180d | 7(4 pending) | +0.00% | +0.35% | +7.82% | -7.90% | -7.90% | — |
| 1y | 7(7 pending) | — | — | — | — | — | — |
| 2y | 7(7 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASE Chief Financial Officer | 12,941 | $16.45 | $212.9K | 118,282 | Apr 23, 2026 | Apr 24, 2026 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE Chief Financial Officer | 12,941 | — | — | 150,000 | Apr 23, 2026 | Apr 24, 2026 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE10b5-1 10b5-1 plan | 12,941 | $25.16 | $325.6K | 105,341 | Apr 23, 2026 | Apr 24, 2026 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE10b5-1 10b5-1 plan | 1,500 | $25.01 | $37.5K | 105,341 | Apr 22, 2026 | Apr 22, 2026 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASE Chief Financial Officer | 1,500 | $16.45 | $24.7K | 106,841 | Apr 22, 2026 | Apr 22, 2026 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE Chief Financial Officer | 1,500 | — | — | 162,941 | Apr 22, 2026 | Apr 22, 2026 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASE Chief Financial Officer | 2,845 | $16.45 | $46.8K | 108,186 | Apr 21, 2026 | Apr 22, 2026 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE Chief Financial Officer | 2,845 | — | — | 164,441 | Apr 21, 2026 | Apr 22, 2026 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE10b5-1 10b5-1 plan | 2,845 | $25.01 | $71.2K | 105,341 | Apr 21, 2026 | Apr 22, 2026 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE Chief Financial Officer | 7,714 | — | — | 167,286 | Apr 20, 2026 | Apr 22, 2026 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASE Chief Financial Officer | 7,714 | $16.45 | $126.9K | 113,055 | Apr 20, 2026 | Apr 22, 2026 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE10b5-1 10b5-1 plan | 7,714 | $25.14 | $193.9K | 105,341 | Apr 20, 2026 | Apr 22, 2026 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 49,091 | — | — | 105,341 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE Chief Financial Officer | 9,104 | — | — | 175,000 | Dec 10, 2025 | Dec 11, 2025 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASE Chief Financial Officer | 9,104 | $16.45 | $149.8K | 65,354 | Dec 10, 2025 | Dec 11, 2025 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE10b5-1 10b5-1 plan | 9,104 | $25.14 | $228.9K | 56,250 | Dec 10, 2025 | Dec 11, 2025 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE10b5-1 10b5-1 plan | 15,896 | $25.03 | $397.9K | 56,250 | Dec 9, 2025 | Dec 11, 2025 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASE Chief Financial Officer | 15,896 | $16.45 | $261.5K | 72,146 | Dec 9, 2025 | Dec 11, 2025 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE Chief Financial Officer | 15,896 | — | — | 184,104 | Dec 9, 2025 | Dec 11, 2025 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE10b5-1 10b5-1 plan | 12,060 | $22.09 | $266.4K | 56,250 | Nov 10, 2025 | Nov 13, 2025 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE Chief Financial Officer | 6,690 | $21.38 | $143.0K | 68,310 | Oct 31, 2025 | Nov 3, 2025 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Nov 4, 2024 | Nov 5, 2024 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Nov 1, 2024 | Nov 5, 2024 ↗ | View → |